Table Info

Table 1.

Clinical characteristics of patients

Parameters	Values (n_total = 122)
Age, year	14.0 [11.0; 16.0]
z Height	0.42 [–0.25; 1.16]
z BMI	0.24 ± 1.04
z FVC	1.11 ± 1.31
z FEV₁	0.31 ± 1.23
z FEV₁/FVC	–1.01 ± 1.26
Change of FEV₁ in tests with bronchodilator, n = 50	1.12 ± 0.11
PNIF, L/min	44.64 ± 13.49
PNIF/FVC	11.05 [7.89; 14.40]
Eosinophils, 10⁹/L	0.28 [0.14; 0.50]
IgE, ME/mL	180.01 [81.55; 384.01]
SNOT-22, scores	16.0 [10.0; 24.0]
Postnasal discharge, scores	1.0 [0.0; 2.0]
Cough, scores	2.0 [1.0; 2.0]
Cough, scores
0: no	23.8% (29/122)
1–2: low intensity	59.0% (72/122)
3–4: medium intensity	17.2% (21/122)

z BMI: z-score body mass index; z Height: z-score height; PNIF: peak nasal inspiratory flow; FVC: forced vital capacity of the lungs; FEV₁: forced expiratory volume in the first second; SNOT-22: Sinonasal Outcome Test-22; IgE: immunoglobulin E. The data is presented in the form of Me [Q1; Q3], where Me is the median, [Q1; Q3] is 1st and 3rd quartiles in the case of an abnormal distribution of quantities, and in the form of M ± σ, where M is the mean value, σ is the standard deviation in the case of their normal distribution

Declarations

Author contributions

RNK: Conceptualization, Resources, Investigation, Methodology, Writing—original draft, Writing—review & editing. SVK: Conceptualization, Resources, Investigation, Methodology, Validation, Visualization, Writing—original draft, Writing—review & editing. ASK: Data curation, Resources, Software, Writing—original draft. KVG: Data curation, Investigation, Methodology, Writing—original draft. DYO: Conceptualization, Methodology, Writing—review & editing. AAK: Data curation, Resources, Software, Writing—original draft. AAS: Data curation, Software. GSI: Data curation, Software, Writing—review & editing. MAK: Data curation, Software, Validation, Writing—original draft. NIK: Writing—review & editing. OVK: Resources, Writing—review & editing. VVN: Writing—review & editing. VAB: Methodology, Writing—review & editing. NAG: Methodology, Writing—review & editing. TIE: Conceptualization, Investigation, Formal analysis, Supervision, Resources, Writing—original draft, Writing—review & editing.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

The study was performed in accordance with the Helsinki Declaration (2013) and approved by the Ethics Committee of the Volga Region Research Medical University (Protocol No. 13 dated 10.10.2016).

Consent to participate

All participants and all primary caregivers provided written informed consent.

Consent to publication

Not applicable.

Availability of data and materials

The data used to support the findings of this study are available from the corresponding author upon request (Nailya I. Kubysheva, aibolit70@mail.ru).

Funding

Not applicable.

Copyright

Publisher’s note

Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.

References

Chang AB, Oppenheimer JJ, Weinberger M, Grant CC, Rubin BK, Irwin RS, et al.; CHEST Expert Cough Panel. Etiologies of Chronic Cough in Pediatric Cohorts: CHEST Guideline and Expert Panel Report. Chest. 2017;152:607–17. [DOI] [PubMed] [PMC]

Shehab N, Hossain J, Yousef E. Variation of asthma characteristics with atopic march, gastroesophageal reflux, and ENT pathologies. J Asthma. 2023;60:1661–7. [DOI] [PubMed]

Rosati MG, Peters AT. Relationships among allergic rhinitis, asthma, and chronic rhinosinusitis. Am J Rhinol Allergy. 2016;30:44–7. [DOI] [PubMed] [PMC]

Eliseeva TI, Krasilnikova SV, Geppe NA, Babaev SY, Tush EV, Khaletskaya OV, et al. Effect of Nasal Obstructive Disorders on Sinonasal Symptoms in Children with Different Levels of Bronchial Asthma Control. Can Respir J. 2018;2018:4835823. [DOI] [PubMed] [PMC]

Nappi E, Paoletti G, Malvezzi L, Ferri S, Racca F, Messina MR, et al. Comorbid allergic rhinitis and asthma: important clinical considerations. Expert Rev Clin Immunol. 2022;18:747–58. [DOI] [PubMed]

Zvezdin B, Hromis S, Kolarov V, Milutinov S, Zarić B, Jovancević L, et al. Allergic asthma and rhinitis comorbidity. Vojnosanit Pregl. 2015;72:1024–31. [DOI] [PubMed]

Poddighe D, Brambilla I, Licari A, Marseglia GL. Pediatric rhinosinusitis and asthma. Respir Med. 2018;141:94–9. [DOI] [PubMed]

Marseglia GL, Caimmi S, Marseglia A, Poddighe D, Leone M, Caimmi D, et al. Rhinosinusitis and asthma. Int J Immunopathol Pharmacol. 2010;23:29–31. [PubMed]

Nakajima T, Nagano T, Nishimura Y. Retrospective Study of the Effects of Post-nasal Drip Symptoms on Cough Duration. In Vivo. 2021;35:1799–803. [DOI] [PubMed] [PMC]

10.

Tian C, Xiong S, Li S, Song X, Zhang Y, Jiang X, et al. Spirometry in the diagnosis of cough variant asthma in children. Pediatr Pulmonol. 2024;59:291–9. [DOI] [PubMed]

11.

Yi F, Jiang Z, Li H, Guo C, Lu H, Luo W, et al. Small Airway Dysfunction in Cough Variant Asthma: Prevalence, Clinical, and Pathophysiological Features. Front Physiol. 2022;12:761622. [DOI] [PubMed] [PMC]

12.

Donaldson AM. Upper Airway Cough Syndrome. Otolaryngol Clin North Am. 2023;56:147–55. [DOI] [PubMed]

13.

Yasuda K. Upper airway cough syndrome may be the main cause of chronic cough in Japan: a cohort study. Fam Pract. 2021;38:751–7. [DOI] [PubMed]

14.

Global Strategy for Asthma Management and Prevention [Internet]. Global Initiative for Asthma; © 2020 [cited 2024 Dec 4]. Available from: https://ginasthma.org/wp-content/uploads/2023/04/GINA-2020-Main-Report-WMSA.pdf

15.

Chuchalin AG, Avdeev SN, Aisanov Z, Belevskiy A, Vasileva OS, Geppe NA, et al. Bronchial asthma: federal clinical guidelines for diagnosis and treatment. Pulmonology. 2022;32:393–447. [DOI]

16.

Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58:1–464. [DOI] [PubMed]

17.

Pite H, Pimenta L, Henriques AC, Marques I, Camarinha C, Lourenco AV, et al. Lower airway flow influences peak nasal inspiratory flow in school-aged children. Rhinology. 2018;56:288–96. [DOI] [PubMed]

18.

Thorstensen WM, Sue-Chu M, Bugten V, Cvancarova M, Steinsvåg SK. The determining factors of peak nasal inspiratory flow and perception of nasal airflow in asthmatics. Rhinology. 2014;52:348–54. [DOI] [PubMed]

19.

Rajvanshi N, Kumar P, Goyal JP. Evaluation of Chronic Cough in Children Using Management Algorithm: A Prospective Cohort Study. Indian J Pediatr. 2024;91:337–43. [DOI] [PubMed]

20.

Bousquet J, Melén E, Haahtela T, Koppelman GH, Togias A, Valenta R, et al. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis. Allergy. 2023;78:1169–203. [DOI] [PubMed]

21.

Athanasiadis T, Allen JE. Chronic cough: an otorhinolaryngology perspective. Curr Opin Otolaryngol Head Neck Surg. 2013;21:517–22. [DOI] [PubMed]

22.

Chung KF, McGarvey L, Song W, Chang AB, Lai K, Canning BJ, et al. Cough hypersensitivity and chronic cough. Nat Rev Dis Primers. 2022;8:45. [DOI] [PubMed] [PMC]

23.

Irwin RS, French CL, Chang AB, Altman KW; CHEST Expert Cough Panel. Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report. Chest. 2018;153:196–209. [DOI] [PubMed] [PMC]

24.

Irwin RS, Baumann MH, Bolser DC, Boulet L, Braman SS, Brightling CE, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:1S–23S. [DOI] [PubMed] [PMC]

25.

Diver S, Russell RJ, Brightling CE. Cough and Eosinophilia. J Allergy Clin Immunol Pract. 2019;7:1740–7. [DOI] [PubMed]

26.

Tiotiu A, Novakova P, Baiardini I, Bikov A, Chong-Neto H, de-Sousa JC, et al. Manifesto on united airways diseases (UAD): an Interasma (global asthma association - GAA) document. J Asthma. 2022;59:639–54. [DOI] [PubMed]

27.

Poddighe D, Brambilla I, Licari A, Marseglia GL. Omalizumab in the Therapy of Pediatric Asthma. Recent Pat Inflamm Allergy Drug Discov. 2018;12:103–9. [DOI] [PubMed]

28.

Principe S, Porsbjerg C, Ditlev SB, Klein DK, Golebski K, Dyhre-Petersen N, et al. Treating severe asthma: Targeting the IL-5 pathway. Clin Exp Allergy. 2021;51:992–1005. [DOI] [PubMed] [PMC]